Our CRO services entail a streamlined workflow that begins with you selecting the PDO models you are interested in and indicating the analysis you require. We will then design a scope of work, carry out the experiment, and furnish you with a report that is custom-tailored to address your specific research question.
Patient-derived organoid screening platform
PDO Screen is built upon the recent success of our organoid screening platform which led to the first oncology agent to be approved for clinical trials within 5 years of development.
Select from an extensive panel of well-characterized patient-derived organoid models from multiple epithelial tissue types, disease indications, and mutational signatures to evaluate the efficacy and prioritize your lead candidate with confidence.
Can’t find what you are looking for? Leverage our state-of-the-art technology to develop new models that meet your specific needs.
NEWS AND INSIGHTS
